A new study at The University of Texas at Arlington could help substantially reduce the amount of radiation heart patients receive during imaging procedures without sacrificing diagnostic accuracy.

First-in-class targeted therapy shows promise against hard-to-treat cancers

Tile-based radiation therapy dramatically reduced recurrence of brain metastases

Targeting individual metastases in oligometastatic breast cancer did not improve survival

Personalized guidance boosts family genetic testing for hereditary cancers

AI tool uncovers signals that either attract immune cells to tumors or keep them out

The JAMA Network announces the launch of JAMA AI, a new peer-reviewed online journal dedicated to publishing clinical research on artificial intelligence, digital health, and emerging technologies that are transforming medicine and health care. JAMA AI will begin accepting submissions in early 2027 and will be the 14th journal in the JAMA Network.

Someone shopping for an over-the-counter (OTC) hearing aid may have to sort through dozens of products, determine which ones are regulated by the FDA, figure out what insurance will cover, and find an expert willing to help choose and set up a device. A new JAMA Viewpoint by UC San Francisco researchers says these hurdles show why making hearing aids available without a prescription, while an important step, has not been enough to ensure people can find and use the devices they need.

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, limiting their ability to keep tumors under control. 

A WashU Medicine project to develop an injectable treatment to reverse tissue damage in osteoarthritis has received $17 million in phase 2 funding from ARPA-H.